Literature DB >> 21274671

B-Raf mutations, microsatellite instability and p53 protein expression in sporadic basal cell carcinomas.

Angeliki Stamatelli1, Angelica A Saetta, Thaleia Bei, Nicolaos Kavantzas, Nicolaos V Michalopoulos, Efstratios Patsouris, Kiriaki Aroni.   

Abstract

Basal Cell Carcinoma (BCC) is the most common skin malignancy. Genes related to the Ras/Raf signalling pathway have been implicated in the pathogenesis of skin cancer. The objective of this study was to investigate the presence of B-Raf mutations in sporadic BCCs as well as its correlation with the phenotype of microsatellite instability (MSI), the clinicopathological parameters of the tumours and p53 protein expression. 83 BCC specimens were screened for B-Raf mutations, applying polymerase chain reaction, single-stranded conformation polymorphism (PCR-SSCP) and DNA sequencing. MSI status was examined using mononucleotide microsatellite markers and p53 protein expression was demonstrated by immunohistochemical staining. A C to T transition at 1790 nucleotide leading to a silent mutation L597L; and a T to A transversion causing an amino acid change (F610I) have been found. MSI was detected in 5% of the cases and p53 accumulation was present in 37/83 samples studied. Although rare B-Raf alterations have been observed in BCC, none of them harboured the hot-spot mutation T1799A commonly present in melanomas and colon carcinomas. Consequently, no correlation could be determined between B-Raf alterations, MSI status, the clinicopathological features and p53 protein expression. Our results are in favour of a secondary importance for Ras signalling cascade genes in BCC pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21274671     DOI: 10.1007/s12253-011-9363-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  29 in total

1.  p53 expression related to the aggressive infiltrative histopathological feature of basal cell carcinoma.

Authors:  Sauvarat Auepemkiate; P Boonyaphiphat; P Thongsuksai
Journal:  Histopathology       Date:  2002-06       Impact factor: 5.087

2.  Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation.

Authors:  Diana N Ionescu; Muammar Arida; Drazen M Jukic
Journal:  Arch Pathol Lab Med       Date:  2006-01       Impact factor: 5.534

3.  Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.

Authors:  T L Barrett; K J Smith; J J Hodge; R Butler; F W Hall; H G Skelton
Journal:  J Am Acad Dermatol       Date:  1997-09       Impact factor: 11.527

4.  Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.

Authors:  J Reifenberger; M Wolter; C B Knobbe; B Köhler; A Schönicke; C Scharwächter; K Kumar; B Blaschke; T Ruzicka; G Reifenberger
Journal:  Br J Dermatol       Date:  2005-01       Impact factor: 9.302

Review 5.  Testing tumors for microsatellite instability.

Authors:  A de la Chapelle
Journal:  Eur J Hum Genet       Date:  1999 May-Jun       Impact factor: 4.246

6.  Overexpression of p53 protein in basal cell carcinomas of human skin.

Authors:  C R Shea; N S McNutt; M Volkenandt; J Lugo; P G Prioleau; A P Albino
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

Review 7.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

Review 8.  Raf proteins and cancer: B-Raf is identified as a mutational target.

Authors:  Kathryn E Mercer; Catrin A Pritchard
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation.

Authors:  Enric Domingo; Eloi Espín; Manel Armengol; Carla Oliveira; Mafalda Pinto; Alex Duval; Caroline Brennetot; Raquel Seruca; Richard Hamelin; Hiroyuki Yamamoto; Simó Schwartz
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  1 in total

1.  TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features.

Authors:  António Castanheira; Maria João Vieira; Mafalda Pinto; Carolina Dias; Luísa Prada; Sofia Macedo; Margarida Sá Fernandes; Fortunato Vieira; Paula Soares; Alberto Mota; José Manuel Lopes; Paula Boaventura
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.